Chinese billionaire Guo Guangchang’s Shanghai-based Fosun Pharmaceutical Group has approached several private equity firms to buy its stake in Hyderabd India-based Gland Pharma according to a report in Money Control Reportedly, Advent International, Baring Private Equity Asia, Bain Capital, Blackstone, Carlyle and KKR are among those who have been approached....